Fresenius Medical Care AG & Co. KGaA Financials

Market Capitalization €14.18 Billion as of July 1, 2025

Valuations Metrics as of Jul. 4, 2025

Trailing PE	22.90
Forward PE	14.17
Price to Sales TTM	€0.73
Price to Book MRQ	€0.99
Enterprise to Revenue	1.29
Enterprise to EBITDA	10.66

Financial Reports as of Mar. 31, 2025

Financials

Fiscal Year Ends	2024-12-31
Most Recent Quarter	2025-03-31
Profit Margin	3.17%
Operating Margin	7.82%
Return on Assets TTM	2.91%
Return on Equity TTM	5.30%

Income Statement

Revenue TTM	€19,492,841,472
Revenue per Share TTM	€66.44
Quarterly Revenue Growth	3.30%
Gross Profit TTM	€4,766,979,072
EBITDA	€2,429,872,000
Net Income to Common TTM	€618,174,976
Diluted EPS TTM	€2.11
Quarterly Earnings Growth YoY	113.10%

Balance Sheet

Total Cash MRQ	€1,071,288,000
Total Cash per Share MRQ	€3.65
Total Debt MRQ	€
Total Debt to Equity MRQ	69.92
Current Ratio MRQ	1.46
Book Value per Share MRQ	€48.98

Cash Flow

Operating Cash Flow TTM	€2,421,659,904
Levered Free Cash Flow TTM	€2,279,664,128

FME Stock Info as of Jul. 4, 2025

Stock Statistics

Shares Outstanding	293,413,449
Float Shares	209,464,927
Avg 10 Volume	507,492
Avg 30 Volume	None
Shares Short	None
Short Ratio
Short % of Shares	%
% Held by Insiders	28.55%
% Held by Institutions	42.65%

Stock Price Summary

Beta	0.85
Fifty Two Week Low	€32.51
Fifty Two Week High	€54.02
Fifty Two Week Change	24.30%
Day 50 MA	€48.71
Day 200 MA	€44.31

Dividends and Splits

Forward Annual Dividend Rate	€5.76
Forward Annual Dividend Yield	12.06%
Trailing Annual Dividend Rate	€1.44
Trailing Annual Dividend Yield	3.01%
Payout Ratio	56.40%
Dividend Date
Ex Dividend Date	2025-05-23
Last Split Factor
Last Split Date	2007-06-18